# 4075
Helen Branswell, medical and science correspondent for the Canadian Press, tracks down what is known about the suspect batch of GSK vaccine which has been pulled from use in Canada due to excess allergic reactions, and answers some questions about anaphylaxis.
For my American readers, THIS RECALL DOES NOT APPLY TO U.S. VACCINES.
While answers about this batch of vaccine are still in short supply, Ms. Branswell asks and answers a number of general questions about anaphylaxis and vaccines.
As with any Branswell article, this is well worth reading.
GSK says still no answer on whether H1N1 vaccine batch triggers more reaction
By Helen Branswell Medical Reporter (CP)
TORONTO — The investigation into whether a batch of H1N1 vaccine may have triggered a higher-than-normal rate of allergic reactions hasn't yet come up with answers, vaccine manufacturer GlaxoSmithKline said Tuesday.
And health officials in Quebec said they are still trying to determine if the death of an elderly man who died of anaphylaxis after receiving a pandemic flu shot was triggered or hastened by the vaccination.
"Investigations being undertaken by GSK, Health Canada and the Public Health Agency of Canada (PHAC) have not yet been completed," GSK spokesperson Megan Spoore said in an email about the pulled batch of vaccine.
Related Post:
- Branswell On Flu Vaccine Matches
- mBio: Coronavirus Has An Affinity For Multiple Hosts
- Branswell On Expanded Surveillance For The Coronavirus
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- SARS Virus Placed On Select Agents List
- Branswell Updates The Novel Coronavirus Story
- Osterholm: Time To Close The Pig Barns
- Branswell On Lifting The H5N1 Research Moratorium
- Pediatrics: Low Uptake Of Flu Vaccine Among Toddlers In Ontario
- NSABB Clears H5N1 Studies For Publication
- NSABB To Re-examine H5N1 Research Risks
- Branswell: WHO Hopes H5N1 Studies Can Be Published By Summer
- Branswell On The Transmissibility Of The H3N2v Virus
- Branswell On the CFR Of H5N1
- Eurosurveillance: Older People May Be Susceptible To The H3N2v Virus
- WHO: Will Host H5N1 Talks In Geneva
- Branswell On The Research Moratorium
- Branswell: WHO on H5N1 Research Controversy
- Publish or Perish The Thought?
- Three Would Make For A Crowded Viral Field
- Branswell: PLoS One Study On Adverse Reactions To MMR Vaccine
- Branswell On The New trH3N2 Flu Virus
- CIDRAP: New Details In The trH3N2 Story
- Branswell On The WHO Response To trH3N2
- More Details On The trH3N2 Story
- Canada Releases Tamiflu From National Emergency Stockpile
- Canada: FluWatch Week 52
- Canada: Another West Coast Temblor
- Haida Gwaii Quake & Tsunami Advisories
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Ontario Confirms H1N1v Case
- EID Journal: Revisiting The `Canadian Problem’
- Alberta, Canada Issues Measles Alert
- IDSA: Educational Guidelines Lower Antibiotic Use
- Webinar: pH1N1 – H3N2 A Novel Influenza Reassortment
- North America Flu Surveillance Week 8
- North America Influenza Surveillance - Week 4
- North America: Flu Surveillance Week 2
- North America: Flu Activity Week 1
- Toronto ERs Seeing Heavy Flu Volume
- North America: H3N2 Driving Our Flu Season
- PHAC: Lessons Learned From The 2009 Pandemic
- Ontario: A Top Ten List Of Infectious Disease Threats
- Eurosurveillance: The Temporary Immunity Hypothesis
- OIE Report: Manitoba Bird Flu Identified As H5N2
- CFIA Statement On Manitoba’s Avian Flu Outbreak
- CTV Reporting Low Path H5 On Canadian Turkey Farm
- CMAJ: Comparing First And Second Pandemic Waves In Canada
- Study: Eurosurveillance On `The Canadian Problem’
- CSA White Paper: Voices From The Front Lines
- Adding To A Feverish Debate
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- FDA Statement On Azithromycin & Cardiovascular Risks
- NEJM: Cardiovascular Risks Of Taking Azithromycin
- Study: PPIs & Increased Pneumonia Risk
- NSAIDs and Prior Heart Attacks
- Japan: Investigating Pediatric Vaccines
- JAMA: Cell Phone Use Stimulates Brain Activity
- Australia: Panvax Investigated For Febrile Convulsions
- EMA To Review Pandemrix Vaccine
- Finland Suspends Use of Pandemrix Vaccine
- Australia: CSL Recalls Pediatric Flu Vax
- Eurosurveillance: Adverse Effects of Oseltamivir in Children
- Scientist’s Theory On Australian Vax Problem
- Australian Vaccine Investigation Widens
- Australia Investigating Adverse Vaccine Reactions
- Canada Probes Adverse Vaccine Reactions
- Hong Kong: No Increase In Fetal Death Among Vaccine Recipients
- Canadian Weekly Vaccine Surveillance Report
- Japan: Small Number of Adverse Vaccine Reactions
- The Double Edged Sword
- A Few Inflammatory Remarks
- The Coincidence Factor
- The Background Is Always In Motion
Widget by [ Iptek-4u ]